Document is current

Any future updates will be listed below

Correction: Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate

Crossref DOI link: https://doi.org/10.1038/s41391-022-00578-7

Published Online: 2022-07-15

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark